i work in an outpatient BMT program where both allo and autologous transplant patients are seen daily at the start of their transplant treatment protocols. Patients continue to be outpatients until an inpatient admission is required. A fever is usually the reason for admissions in the early phases of transplant. If patient is stable we give IV ceftriaxone 1 gm q 24 hours. However, if fevers persist, cultures are positive or patient becomes unstable they are admitted for pip/tazo or treatment specific to culture sensitivity. We use neupogen day +7 for all of our autologous bmt patients. this is covered under the hospital admission. although, i am in Canada, so insurance is not an issue for our transplant patients when they are undergoing therapy as an inpatient.